MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $64 million versus the consensus estimate of $63.45 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.